Colgate Palmolive (India) valuation

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Price multiples — at each FY-end close
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
32.55×————
27.40×————
6.94×————
25.62×————
Yield
3.1%————
3.9%————
Reference — adjusted share basis
₹1,629.80————
₹50.07₹48.73₹52.83₹48.67₹38.50
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

COLPAL₹1,629.80

Colgate Palmolive (India) Ltd.

· FMCG & Retail
₹ CrorePeersHINDUNILVRDABURMARICOPATANJALIRADICOGODFRYPHLPVBLUNITDSPRMcap ₹44,326 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Price Multiples — at each FY-end close
P/E————32.55
P/B————27.40
P/Sales————6.94
Price to Free Cash Flow————25.62
Yield
Earnings Yield %————3.07
FCF Yield %————3.90
Reference — adjusted share basis
Price (FY-end close, adj.)————1,629.80
EPS (adj.)38.5048.6752.8348.7350.07
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.